Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 654727, 9 pages
http://dx.doi.org/10.1155/2014/654727
Research Article

IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients

1Molecular Medicine Center, Medical University of Sofia, 2 Zdrave Street, 1431 Sofia, Bulgaria
2Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, 2 Zdrave Street, 1431 Sofia, Bulgaria
3Department of Neurosurgery, University Multiprofile Hospital for Active Treatment and Emergency Medicine “N.I.Pirogov”, 21 Totleben Boulevard, 1606 Sofia, Bulgaria
4Department of Pathology, University Multiprofile Hospital for Active Treatment and Emergency Medicine “N.I.Pirogov”, 21 Totleben Boulevard, 1606 Sofia, Bulgaria

Received 20 February 2014; Accepted 29 March 2014; Published 24 April 2014

Academic Editor: Eiichi Ishikawa

Copyright © 2014 Gergana Stancheva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gergana Stancheva, Teodora Goranova, Maria Laleva, et al., “IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients,” BioMed Research International, vol. 2014, Article ID 654727, 9 pages, 2014. https://doi.org/10.1155/2014/654727.